Broadwood Capital Inc

Investment Portfolio & 13F Holdings Analysis

About

BROADWOOD CAPITAL INC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 8 holdings worth $1.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "STAA",
  "LCTX",
  "SER",
  "MNST",
  "OCX",
  "AXON",
  "OLO",
  "IWM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 8
Total Value: 1234437659
Accession Number: 0000919574-25-003088
Form Type: 13F-HR
CIK: broadwood-capital
Manager Name: Broadwood-Capital

Data Enrichment

100% identified

8 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

8 positions • $1,234,437.659K total value

8 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

Monster Beverage Corp

MNST|61174X109

Shares:8.3M

Value:$485.5M

AXON ENTERPRISE, INC.

AXON|05464C101

Shares:696.1K

Value:$366.1M

STAAR SURGICAL CO

STAA|852312305

Shares:12.5M

Value:$219.6M

464287655

IWM|464287655

Shares:474.9K

Value:$94.7M

Oncocyte Corp

OCX|68235C206

Shares:11.4M

Value:$34.9M

Lineage Cell Therapeutics, Inc.

LCTX|53566P109

Shares:49.6M

Value:$22.4M

Olo Inc.

OLO|68134L109

Shares:1.8M

Value:$10.8M

Serina Therapeutics, Inc.

SER|81751A108

Shares:85.2K

Value:$483.2K

Instrument	Shares		Other Manager	Value
Monster Beverage Corp(MNSTcusip61174X109)	8.3M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$485.5M	QoQ +11.33% (+$49.4M) YoY -1.28% (-$6.3M)
AXON ENTERPRISE, INC.(AXONcusip05464C101)	696.1K	QoQ -3.64% (-26.3K) YoY -8.41% (-64.0K)	All Managers (Combined)	$366.1M	QoQ -14.73% (-$63.2M) YoY +53.94% (-$128.3M)
STAAR SURGICAL CO(STAAcusip852312305)	12.5M	QoQ +14.80% (-1.6M) YoY +15.66% (-1.7M)	All Managers (Combined)	$219.6M	QoQ -16.66% (-$43.9M) YoY -46.73% (-$192.6M)
(IWMcusip464287655)	474.9K	QoQ -8.65% (-45.0K) YoY -16.09% (-91.1K)	All Managers (Combined)	$94.7M	QoQ -17.53% (-$20.1M) YoY -20.40% (-$24.3M)
Oncocyte Corp(OCXcusip68235C206)	11.4M	QoQ +82.72% (+5.2M) YoY +354.75% (+8.9M)	All Managers (Combined)	$34.9M	QoQ +134.93% (+$20.1M) YoY +374.93% (+$27.6M)
Lineage Cell Therapeutics, Inc.(LCTXcusip53566P109)	49.6M	QoQ +18.94% (+7.9M) YoY +18.94% (-7.9M)	All Managers (Combined)	$22.4M	QoQ +6.89% (+$1.4M) YoY -63.70% (-$39.3M)
Olo Inc.(OLOcusip68134L109)	1.8M	QoQ NEW(+1.8M) YoY NEW(+1.8M)	All Managers (Combined)	$10.8M	QoQ NEW(+$10.8M) YoY NEW(+$10.8M)
Serina Therapeutics, Inc.(SERcusip81751A108)	85.2K	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$483.2K	QoQ +13.17% (+$56.2K) YoY -57.87% (-$663.9K)